Beyond contributing to the conceptual knowledge of appetite and energy balance regulation in humans [12], we also made potentially clinically important discoveries, such as why dietary protein provides greater immediate satiety than the other macronutrients and why milk is more satiating than sugar-sweetened soft drinks (both dietary exposures increase GLP-1 relative to their comparators) [13]
In trials, Mounjaro has been shown to lead to weight loss of up to 21% to 22.5% at the highest dose, which is comparable to the weight loss achieved through bariatric surgery
Weight Loss: Clinical trials have indicated significant weight loss, comparable to injectable forms
Risks include unregulated product quality , reconstitution errors , injection-site infection and inappropriate dose or cycle for your goal
Overall, these results indicate that semaglutide exerts its beneficial effects via a multi-organ mechanism involving modulation of inflammatory and oxidative pathways, reinforcement of intestinal barrier integrity and regulation of extracellular matrix turnover
The Obesity Action Coalition and The Obesity Society sent a letter urging the FDA to enforce federal regulations around compounding following the recent resolution of GLP-1 medicine shortages